Saturday, July 11, 2026

Drug profile · INN

nirmatrelvir and ritonavir

nirmatrelvir and ritonavir (PAXLOVID (NOTE 2)) is an FDA-listed pharmaceutical active ingredient.

PMDA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — nirmatrelvir and ritonavir
Class
Route
Patents
0
Programs
0
Data quality
0.78

Quick answer

nirmatrelvir and ritonavir (PAXLOVID (NOTE 2)) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN nirmatrelvir and ritonavir
Brand PAXLOVID (NOTE 2)

Approval history

Authority Status Date
PMDA approved

Frequently asked questions

What is nirmatrelvir and ritonavir?

nirmatrelvir and ritonavir (PAXLOVID (NOTE 2)) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for nirmatrelvir and ritonavir?

PAXLOVID (NOTE 2) is a marketed brand name for nirmatrelvir and ritonavir. Check FDA Drugs@FDA for the current US label holder and prescribing information.